OSE Immunotherapeutics (PAR: OSE)

Last close As at 10/02/2025

EUR6.39

0.02 (0.31%)

Market capitalisation

EUR141m

OSE Immunotherapeutics (OSE) is based in Nantes and Paris in France and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharma companies.

Latest Insights

View More
OSE-Immunotherapeutics_resized

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Analyst, Healthcare

Key Management

  • Dominique Costantini

    Chairman

  • Nicolas Poirier

    CEO

Update

Healthcare

OSE Immunotherapeutics — Tedopi remains focus in FY22

edison tv

Healthcare

OSE Immunotherapeutics – executive interview

Update

Healthcare

OSE Immunotherapeutics — Progress with key R&D assets

Initiation

Healthcare

OSE Immunotherapeutics — Immunotherapy research engine